Copyright limitations and exceptions are important limits to the exclusive rights of the copyright holder, permitting use of copyrighted works without the right holder’s permission in certain cases. Under international law, some specific limitations and exceptions exist, such as those enumerated by the Berne Convention. Continue Reading
start  |
| From left to right, USPTO Director David Kappos, President Obama, Pablo Lecuona of Tiflolibros and Melanie Brunson of the ACB |
On 19 November 2012, the European Union announced to WIPO’s Standing Committee on Copyright and Related Rights (SCCR) that it now had the mandate to “negotiate the conclusion conclusion of an instrument including a binding treaty” for the blind.
EUROPEAN UNION
Statement by the European Union and its Member States 25th Session of WIPO Standing Committee on Copyright and Related Rights
Mr Chairman,
Egypt, on behalf of the African Group, delivered the following general intervention at the beginning of WIPO discussions at the 25th Standing Committee on Copyright and Related Rights (SCCR). This was taken from the WIPO live stream of SCCR negotiations: http://www.streamtext.net/player?event=WIPO
|
| Maryanne Diamond and Chris Friend of the WBU listen to opening interventions at SCCR 25 |
Update: November 17, 2012, 10:27pm: The report was removed from the RSC website on Saturday afternoon.. Paul Teller, Executive Director of the RSC issued the following statement:
It was a papal conclave save for the plume of white smoke. At 17h04 on Thursday, 15 November 2012, the board of the Global Fund to Fight AIDS, Tuberculosis and Malaria announced that Dr Mark Dybul would be the organization’s next Executive Director following a process marked by opacity and secrecy that would do the Vatican proud. Dybul (former United States Global AIDS Coordinator) beat a field of three other candidates that included, Monique Barbut (France), Robert Greenhill (Canada) and Barbara Stocking (United Kingdom of Great Britain and Northern Ireland). Continue Reading
On 12 November 2012, Ecuador issued a compulsory license on abacavir/lamivudine. (attached here) This follows the issuance of Ecuador’s first compulsory license in 2009 on ritonavir/lopinavir. Continue Reading
Earlier this year, in the case In re K-Dur, the Court of Appeals for the Third Circuit found that reverse settlement agreements, also known as “pay-for delay” arrangements, were prima facie evidence of anticompetitive behavior. The court noted that the presumption that such payments are unreasonable restraints of trade can be rebutted by a showing that the payment either offered a pro-competitive benefit or that the payment was for a purpose other than delayed entry into the market of generics. Continue Reading
Mark Rohrbaugh has written to Krista Cox to acknowledge the October 25, 2012 march-in petition. According to Rohrbaugh, the petition has be delegated to NIH’s Office of Technology Transfer (OTT), and “NIH has begun to review the issues you have brought to our attention.” Rohrbaugh closes by saying “We expect to respond to your request by the end of the year.” Continue Reading